Cancer therapy may need to be scaled back or stopped altogether except for people with the highest need and likely benefit during the COVID-19 pandemic, new guidelines suggest. To manage limited resources when oncology services are disrupted by shutdowns and staff shortages, prioritisation by treatment intent should favour curative therapy before adjuvant and non-curative therapy, ...
Guidelines released on prioritisation of cancer therapy during COVID-19
By Michael Woodhead
16 Apr 2020